Marshall Wace North America’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,149
| Closed | -$82K | – | 1509 |
|
|
2019
Q2 | $82K | Sell |
3,149
-324
| -9% | -$8.44K | ﹤0.01% | 1075 |
|
|
2019
Q1 | $89K | Buy |
+3,473
| New | +$89K | ﹤0.01% | 1134 |
|
|
2018
Q4 | – | Sell |
-36,313
| Closed | -$1.17M | – | 1607 |
|
|
2018
Q3 | $1.17M | Sell |
36,313
-381,479
| -91% | -$12.2M | 0.01% | 584 |
|
|
2018
Q2 | $11.8M | Buy |
417,792
+115,172
| +38% | +$3.26M | 0.07% | 288 |
|
|
2018
Q1 | $10.7M | Sell |
302,620
-25,468
| -8% | -$902K | 0.05% | 380 |
|
|
2017
Q4 | $12.7M | Buy |
328,088
+59,927
| +22% | +$2.33M | 0.07% | 323 |
|
|
2017
Q3 | $8.05M | Buy |
268,161
+69,342
| +35% | +$2.08M | 0.05% | 424 |
|
|
2017
Q2 | $5.97M | Buy |
198,819
+986
| +0.5% | +$29.6K | 0.04% | 451 |
|
|
2017
Q1 | $5.94M | Buy |
+197,833
| New | +$5.94M | 0.05% | 358 |
|
|
2013
Q3 | – | Sell |
-7,512
| Closed | -$251K | – | 691 |
|
|
2013
Q2 | $251K | Buy |
+7,512
| New | +$251K | 0.02% | 374 |
|